Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How interesting...........a few of you mentioned a possible NASDAQ listing and completely by-passing the OTCQB I believe something else is happening as well as a uplisting should have transpired by now. Unfortunately the share price would need a $3.00 minimum but that would be in the rear-view mirror with positive data from the trial. Charts signal another run up and volume has been light; shares being held. MF giving us a speechless signal with his purchases in the open market, kudos to him.
How interesting...........a few of you mentioned a possible NASDAQ listing and completely by-passing the OTCQB I believe something else is happening as well as a uplisting should have transpired by now. Unfortunately the share price would need a $3.00 minimum but that would be in the rear-view mirror with positive data from the trial. Charts signal another run up and volume has been light; shares being held. MF giving us a speechless signal with his purchases in the open market, kudos to him.
What a volatile week and I see a few of you including myself added during the market dump. MF buying in the open market again signals his confidence with his managed company. The importance of having dry powder at your disposal was evident this week as I was able to pick up more shares and I extended that notion to a few of my friends via text. The immediate response is "what's wrong with the company", typical old fashion tree shaking as the MM's attempt to scare novice investors. I received a few texts yesterday "should I dump this?" freaking knuckle heads "NO add you donkeys this is a gift." As the market was nearing 4pm some friends were already up 10% on Friday morning purchases; feedback was positive but again 'know what you own' stay the course. Have a great weekend everybody and if see a swing like this again I hope you have some dry powder in your war chest. GL.
If you like red, grab yourself a bottle of Rodney Strong Cabernet Sauvignon from Sonoma county, lights out fantastic.
I disagree with your assessment. As shareholders I would expect investors to critique the direction or decision making of the company as it shows the individual has skin in the game and cares, just because you have an opinion it doesn't make it wrong. Those individuals who continually bash clearly don't understand and are simply trolls looking to rattle people's cages. I like a good debate and I don't find them offensive provided they explain their dissatisfaction. Revive is solid and transparent, no worries here.
Interesting times for value investors; as Warren Buffet declares ' if you liked it at a higher valuation why wouldn't love it when it's discounted" Nothing has changed here as most psychedelics were under water today. I grabbed a few as we bounce around support levels and the RSI at 36ish. Huge secular rotation going on as retail/real estate and oil see some nice gains. MF buying shares is a vote of confidence, it's a declaration without actually speaking. I'm still convinced mid-March will be our time to shine as that is my expectation that we see some data. Those of you thinking about a possible buyout? I won't discount that notion only because we haven't seen a merger or acquisition in this space yet. Upwards and onwards as the daily fluctuations don't trouble me; good luck longs.
I'm unaware of some of the people's investment knowledge here on the forum but I think some of you need to do a little reading.
- Frank and his team can't sell shares because of continued material news in the pipeline so stop saying "he hasn't sold any shares" therefore news must be good; again he can't.
- lastly stop emailing the guy, what do you possibly think a CEO is going to reveal to you? You do realize he's bound to secrecy and securities law. Do you believe he would give you and not the public any type of insight? I read these posts and they are hilarious, stop asking for updates and/or details your embarrassing yourself. All relevant information is on Sedar and their website, MF is doing great.
Exceptional news yesterday and I'm not surprised the price didn't explode higher. Every dip was bought aggressively and the MM's were dumping 1000 shares into the bid to prevent the increase however the end of the day they slowly allowed it to rise; dirty bastards they hold all the keys. Monday will be interesting and I suspect a short attack and an unwinding of some short positions therefore we may see a dip at the open. Having invested in the pharma space prior to Revive these types of releases are immediately followed by data; my guess is two weeks from now. My interpretation from the latest release is that we are going to receive topline data and with that release we get a hint that the EAU is being reviewed or Revive has been given the authority and approval to proceed with distribution of Bucillamine, exciting times.
Very important week ahead; the pennant established February 12th. signaled a big bullish trend ahead however it could be a head fake if we fail to defend/support $0.58 CDN on the close this week. I'm expecting a couple of pull backs this week during market hours with closes at or above $0.58
if you have some dry powder and believe the next move is up you should be able to pick up some cheapies around $0.53 - $0.55
On a positive note we are definitely consolidating; Friday's low volume tells us investors are holding their shares, MM's will attempt to shake the tree as we near the end of February - watch the volume for for direction.
I would agree with that directive coming from the FDA. Analysis from the 210 patients gives the FDA something to pondering about hence EUA approval and during the interim they can analyze the forth coming data from patients 400 - 1000
We can see this feedback anytime now; buckle up!
I think we do get news next week regarding the full subscription, Monday would be nice but I doubt it. I don't see any catalyst that would move the share price other than psychedelic news or the big mover that everyone is expecting the data from the 210 enrollment. What I like about the charts is that Revive is trending at the upper end within the wedge pattern. A close above $0.57 this week will confirm a continuation wedge (very bullish). RSI at 46 is positive and the stock defended the 50 EMA; very positive, here's to a higher share price!
Work on your math 'hotmeat' $0.50 to $0.70 is 40% and Revive took a 20% haircut on the announcement. Creating doubt for other investors? How does benefit me? I'm invested here and reloaded @ $0.49 as novice investors and shorts sold/dumped on news; again as long as the directive doesn't align with you it's wrong?
It's a sh1t deal knowing what's in the pipeline and yes! MF just proved that he is either a rookie, desperate or had another motive, raising money below the weighted average is a rookie move; like it or lump it.
lots of reasons and variables on the private placement and everybody here have given their opinions but, in my opinion this was simply terrible. I've been trading and doing analysis for 30 years and I believe MF jumped on the first offer; not because he wanted to but because he had to in order to fund the research and the trial. The most recent funding has come from diluting it's shareholders through (ATM) a lot of start-ups do and it stands for at-the-market, as in “at-the-market offerings.” In an ATM, a listed company sells newly issued shares incrementally into the existing trading marketing through a broker-dealer, at market prices. I've calculated the last 30 trading days and Revive averaged $0.61 and MF does a placement @ $0.50 ? Let's go with that, but the warrants @ $0.70 people for 36 months; come on. This was a gift to Canaccord Genuity Corp. and Leede Jones Gable Inc. The price has rebounded which is positive but I'm sorry the timing of this deal goes to show that the CEO is a rookie and potentially padded the pockets of a few buddies over at Canaccord. I'm a shareholder and like the direction the company is going but this sucks for all of us longs. The bulls here will strongly disagree with my opinion and convince you otherwise but the facts are the facts; take the blinders off and look at the structure of this placement.
The December 23rd. news release that stated:
"The Company’s clinical safety team has actively monitored the ongoing interim data of patients and found there have been no safety concerns and no severe adverse events during the interim analysis enrollment period"
Revive has had a lot of positive news releases and recent hiring's being subject matter experts to do such a low offering.
Volume indicates something is brewing in the background; shorts getting out? I believe so; the latest short position has decreased according to the January 18th report on shortdata.ca
https://shortdata.ca/stock/RVV.CN/
A few scenario's unfolding here; 20 DMA seems to be a level of support and the flip side is that we are making lower highs the last 2 months. I'm looking forward to the short report for January 15th. and see if it has gone up or down. A lot of accumulation going on I'm just interested on who's accumulating longs or shorts. Anticipating news some time next week but certainly by the end of the month. good luck longs.
My point exactly; the U.K. is introducing Roche' arthritis drug, Japan is now looking to administer similar arthritis medication and bucillamine sits and waits for FDA approval. The FDA have the 30 year data yet they continue to pump big pharma and their bunk weed. Yes bunk weed, I truly hope some of these vaccines work but what will the long term effects be? I will take every precautionary measure necessary; PPE, distancing etc. but I will not take the vaccine. Canada has decided to vaccinate prisoners....have at it.
I totally agree with what your saying hotmeat; my sentiments as well.
Don't assume shorts are accumulating, they could also be unwinding positions.
As I mentioned before, I figured we would come back down and retest support, I've added again.
I know hotmeat, I'm aware of the process, I was just making a funny. Exciting times ahead.
That is good news but we need great news from Revive; FDA needs to wake up!
MF needs to light a fire under their backsides and get Bucillamine to the people.
Happy Thursday everyone, I'm still expecting a little pull back and some consolidation around $0.46 - $0.47 mark thus lowering the RSI before the next run. I'm predicating a test at the 52 week high at least one more time before setting new highs, get ready to add.
As much as I would like to see this slowly climb prior to the news release I expect a slight pull back before the eventual share price launch, but that's me looking at the technical's.
Nice post LT1990 and strongly agree with the direction of the share price.
I had a feeling they were diluting, that's 19 million more than the last print count in November; a very good reason the share price is stagnant as the company sells into strength.
is there a potential for it to go parabolic - Resounding YES
Market cap @ 1 billion would fetch roughly $3.85 CDN.
The word is slowly getting out there and people are doing there DD, I think all the talk of the new variant have people wondering about the effectiveness of the vaccine and individuals are looking for alternatives. January 2021 will be our month and by coincidence also the kickoff of the year.
As expected, I'm assumed an uptick at the open and then downward pressure, let's see if yesterdays close holds.
Your first bio stock is a wise choice, good luck with your investments.
The impatient?
Who has a crystal ball?
Is this going up or down?
Why did you buy the stock in the first place?
What's your timeline?
From what I'm reading your here for a quick buck and that's okay. Your worried about a $0.15 profit lol, move on, your not an investor your a stock trader.
If you have truly completed a thorough background check on Revive and understand where the company is going you would hold your core position then add.
Appreciate the feedback, nice to see other investors perspectives and reasonings, good luck.
ITK
I've got to ask, only because I'm interested on how other investors dollar cost average or reload; you do mention on a regular basis that you 'add' what does that look like?
1000 shares 5000 shares
I've been doing this along time and my investment thesis is not to chase, however having a good base is important.
Revive's story line only gets better with each passing day. The last 6 months we have had an opportunity to read some great news releases and watch the companies drug portfolio grow; this little company is making headways and MF has guided the ship well. An inclusion to a ETF would be unbelievable and only means that a good percentage of the share float will be bought up therefore less shares to float around. It would be interesting if this comes to fruition and what percentage of the weighting Revive will have in the ETF, I would guess that Mind Medicine will be right up there.
Get along boys!
Keep you eyes on the prize, we are all here for a reason, deep down we believe that Revive will succeed and that success will provide some of us longs a great payday. Stay focused.
Thanks for posting Revive on the Frankfurt exchange but they normally follow what happens in North America. Let's see today's direction, I'm guessing flat/sideways.
Like any invested stock, it's a roller coaster - ups and downs, peaks and valleys. Last month most of us longs were wondering why we were stagnant and then boom! We will see this cycle again but i believe the next one might be off the charts, hold your shares.
Drink to that!
That would be great if had interim data.
I would be very surprised to see any news this week (hopefully I'm wrong) and feel that if we do get news it will be January 4th/5th. at the earliest. We know Revive would need to have in-depth conversations with the FDA and would need to go over the data extensively. January 11th. makes sense.
I've been doing a ton of reading on different website's and the vast majority of people are hung up on the promise of the vaccine and the cheerleading of big pharma. Well! looks like the FOMO crowd has fallen to prey to big pharma and therapeutics continue to fly under the radar and unloved. Let's hope the news released December 23rd.can be followed up with positive results and approval for EAU.
So here we are December 26th. and absorbing an onslaught of information and anticipating what could be the next big therapeutic company, move over Kevin O'Leary. Revive's journey has just begun and the portfolio continues to impress; we should be so lucky to be invested here at the early stages.
I never cared for Monday's but Revive has somewhat changed that as I'm excited to see what develops next.